Extension Study Of Tanezumab In Osteoarthritis

Stopped early · Phase 3

Conditions studied: Osteoarthritis

In brief

Safety extension study of Phase 3 Osteoarthritis trials with Tanezumab

Key facts

Study ID
NCT00809783
Run by
Pfizer
People needed
2147
Starts
2009-02-06
Expected to finish
2011-06-23
Last updated by the study team
2021-05-10

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.